Hikal

{
  "main_header": {
    "sid": 175814,
    "name": "Hikal",
    "stock_name": "Hikal",
    "full_name": "Hikal Ltd",
    "name_url": "stocks-analysis/hikal",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "232.75",
    "chg": 4.9,
    "chgp": "2.15%",
    "dir": 1,
    "prev_price": "227.85",
    "mcapval": "2,866.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524735,
    "symbol": "HIKAL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE475B01022",
    "curr_date": "Sep 23, 03:30 PM",
    "curr_time": "03:41 AM",
    "last_traded_at": "Sep 23, 03:30 PM IST",
    "bse_nse_vol": "14.03 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 23, 2026",
    "traded_date_str": "2026 09 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hikal-175814-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hikal Ltd Downgraded to Sell Amid Weak Fundamentals and Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hikal-ltd-downgraded-to-sell-amid-weak-fundamentals-and-mixed-technical-signals-4194471",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HikalLtd_mojoScore_4194471.png",
        "date": "2026-09-16 08:31:24",
        "description": "Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 15 Sep 2026. This decision follows a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a deteriorating outlook despite some valuation appeal. The downgrade comes amid a 5.58% drop in the stock price and ongoing underperformance relative to benchmarks."
      },
      {
        "title": "Hikal Ltd Gains 8.87%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-gains-887-4-key-factors-driving-the-weeks-volatility-4192200",
        "imagepath": "",
        "date": "2026-09-13 15:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Stock opens week at Rs.201.75, down 1.15%</p>\n                    <p><strong>1 Sep:</strong> Technical momentum shifts amid bearish signals</p>\n                    <p><strong>3 Sep:</strong> Intraday high surge of 11.89%, closing at Rs.241.20 (+19.97%)</p>\n                    <p><strong>4 Sep:</strong> Shares hit intraday low amid price pressure, closing at Rs.222.20 (-7.88%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.204.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"st..."
      },
      {
        "title": "Hikal Ltd Gains 1.22%: 5 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-gains-122-5-key-factors-driving-the-weeks-mixed-momentum-4191787",
        "imagepath": "",
        "date": "2026-09-12 17:07:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>7 Sep:</strong> Intraday high surge to Rs.236.60 with 10.96% gain</p>\n                    <p><strong>7 Sep:</strong> Heavy volume and institutional buying push price to Rs.241.49</p>\n                    <p><strong>8 Sep:</strong> Mojo Score upgraded to Hold amid bullish technical shift</p>\n                    <p><strong>11 Sep:</strong> Mildly bullish momentum with 2.43% decline to Rs.234.95</p>\n                    <p><strong>11 Sep:</strong> Week closes at Rs.224.90, outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.222.20</div></div>..."
      },
      {
        "title": "Hikal Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-technical-momentum-shifts-amid-mixed-market-signals-4189687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HikalLtd_technicaldot_4189687.png",
        "date": "2026-09-11 08:00:35",
        "description": "Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent dip in price, key indicators such as MACD and moving averages suggest a cautiously optimistic outlook, while other signals like KST and Bollinger Bands present a more complex picture for investors to consider."
      },
      {
        "title": "Hikal Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hikal-ltd-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-4185924",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HikalLtd_mojoScore_4185924.png",
        "date": "2026-09-08 08:29:51",
        "description": "Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 7 September 2026. This change reflects a notable improvement in technical indicators amid persistent financial headwinds, prompting a reassessment of the stock’s near-term outlook despite ongoing fundamental concerns."
      },
      {
        "title": "Hikal Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-technical-momentum-shifts-to-bullish-amid-strong-price-gains-4185453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HikalLtd_technicaldot_4185453.png",
        "date": "2026-09-08 08:00:41",
        "description": "Hikal Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish to a bullish stance, supported by strong daily moving averages and positive MACD signals. This technical upgrade accompanies a robust 9.38% surge in the stock price, reflecting renewed investor confidence in the pharmaceuticals and biotechnology sector amid broader market fluctuations."
      },
      {
        "title": "Hikal Ltd Surges on Heavy Value Trading and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-surges-on-heavy-value-trading-and-institutional-interest-4185231",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HikalLtd_most_active_equities_by_value_4185231.png",
        "date": "2026-09-07 15:00:07",
        "description": "Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 7 September 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector and the broader market, reflecting renewed investor confidence despite a recent downgrade in its Mojo Grade."
      },
      {
        "title": "Hikal Ltd Surges on Exceptional Volume Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-surges-on-exceptional-volume-amid-sector-outperformance-4185230",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HikalLtd_most_active_equities_by_volume_4185230.png",
        "date": "2026-09-07 15:00:07",
        "description": "Hikal Ltd witnessed a remarkable surge in trading volume on 7 September 2026, emerging as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector. The stock outperformed its sector peers and the broader market, driven by strong investor participation and technical momentum despite a recent downgrade in its Mojo Grade."
      },
      {
        "title": "Hikal Ltd Surges 10.96% to Day's High of Rs 236.6 — Outperforms Sector by 5.51 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hikal-ltd-hits-intraday-high-with-1096-surge-on-7-september-2026-4184990",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/HikalLtd_priceRelatedfactors_4184990.png",
        "date": "2026-09-07 10:46:29",
        "description": "The Sensex declined by 0.39% on 07 Sep 2026, while Hikal Ltd surged 10.96%, reaching an intraday high of Rs 236.6. This 5.51 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally in a broadly weak market environment."
      }
    ],
    "total": 477,
    "sid": "175814",
    "stock_news_url": "https://www.marketsmojo.com/news/hikal-175814"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "22-Sep-2026",
      "details": "Press Release- Hikal ventures into Personal Care: New cGMP Panoli facility begins Commercial Production.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Sep-2026",
      "details": "Intimation of Analyst and Investor meet pursuant to regulations 30 of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "01-Sep-2026",
      "details": "Newspaper Publication informing about 38th Annual General Meeting and information on e-Voting.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hikal Ltd has declared <strong>20%</strong> dividend, ex-date: 04 Sep 26",
          "dt": "2026-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Hikal Ltd has announced <strong>2:10</strong> stock split, ex-date: 27 Feb 15",
          "dt": "2015-02-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hikal Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 18",
          "dt": "2018-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Hikal Ltd Downgraded to Sell Amid Weak Fundamentals and Mixed Technical Signals

2026-09-16 08:31:24

Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 15 Sep 2026. This decision follows a comprehensive reassessment of the company’s quality, valuation, financial trends, and technical indicators, reflecting a deteriorating outlook despite some valuation appeal. The downgrade comes amid a 5.58% drop in the stock price and ongoing underperformance relative to benchmarks.

Read full news article

Hikal Ltd Gains 8.87%: 4 Key Factors Driving the Week’s Volatility

2026-09-13 15:00:05

Key Events This Week

31 Aug: Stock opens week at Rs.201.75, down 1.15%

1 Sep: Technical momentum shifts amid bearish signals

3 Sep: Intraday high surge of 11.89%, closing at Rs.241.20 (+19.97%)

4 Sep: Shares hit intraday low amid price pressure, closing at Rs.222.20 (-7.88%)

Week Open

Rs.204.10

Week Close

Read full news article

Hikal Ltd Gains 1.22%: 5 Key Factors Driving the Week’s Mixed Momentum

2026-09-12 17:07:30

Key Events This Week

7 Sep: Intraday high surge to Rs.236.60 with 10.96% gain

7 Sep: Heavy volume and institutional buying push price to Rs.241.49

8 Sep: Mojo Score upgraded to Hold amid bullish technical shift

11 Sep: Mildly bullish momentum with 2.43% decline to Rs.234.95

11 Sep: Week closes at Rs.224.90, outperforming Sensex

Week Open

Rs.222.20

...

Read full news article

Hikal Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-09-11 08:00:35

Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent dip in price, key indicators such as MACD and moving averages suggest a cautiously optimistic outlook, while other signals like KST and Bollinger Bands present a more complex picture for investors to consider.

Read full news article

Hikal Ltd Upgraded to Hold by MarketsMOJO Amid Mixed Financial and Technical Signals

2026-09-08 08:29:51

Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 7 September 2026. This change reflects a notable improvement in technical indicators amid persistent financial headwinds, prompting a reassessment of the stock’s near-term outlook despite ongoing fundamental concerns.

Read full news article

Hikal Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains

2026-09-08 08:00:41

Hikal Ltd has witnessed a significant shift in its technical momentum, moving from a mildly bullish to a bullish stance, supported by strong daily moving averages and positive MACD signals. This technical upgrade accompanies a robust 9.38% surge in the stock price, reflecting renewed investor confidence in the pharmaceuticals and biotechnology sector amid broader market fluctuations.

Read full news article

Hikal Ltd Surges on Heavy Value Trading and Institutional Interest

2026-09-07 15:00:07

Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 7 September 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector and the broader market, reflecting renewed investor confidence despite a recent downgrade in its Mojo Grade.

Read full news article

Hikal Ltd Surges on Exceptional Volume Amid Sector Outperformance

2026-09-07 15:00:07

Hikal Ltd witnessed a remarkable surge in trading volume on 7 September 2026, emerging as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector. The stock outperformed its sector peers and the broader market, driven by strong investor participation and technical momentum despite a recent downgrade in its Mojo Grade.

Read full news article

Hikal Ltd Surges 10.96% to Day's High of Rs 236.6 — Outperforms Sector by 5.51 Percentage Points

2026-09-07 10:46:29

The Sensex declined by 0.39% on 07 Sep 2026, while Hikal Ltd surged 10.96%, reaching an intraday high of Rs 236.6. This 5.51 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally in a broadly weak market environment.

Read full news article

View All News